Search

Your search keyword '"Dower, Ken"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Dower, Ken" Remove constraint Author: "Dower, Ken"
39 results on '"Dower, Ken"'

Search Results

1. A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetes

2. Stricturing Crohn’s Disease Single-Cell RNA Sequencing Reveals Fibroblast Heterogeneity and Intercellular Interactions

4. Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation

5. Stricturing Crohn's disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions

6. Identification of a Broadly Fibrogenic Macrophage Subset Induced by Type 3 Inflammation in Human and Murine Liver and Lung Fibrosis

8. The Interleukin‐1 Receptor–Associated Kinase 4 Inhibitor PF‐06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial

11. Pharmacologic inhibition of Protein Kinase C α and Protein Kinase C β halts renal function decline indirectly, by blunting hyperphagia, and directly reduces adiposity in the ZSF1 rat model of type 2 diabetes

12. A tumor host range selection procedure identifies p[150.sup.sal2] as a target of polyoma virus large T antigen

13. TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines

14. Stimulation of TLR4 by recombinant HSP70 requires structural integrity of the HSP70 protein itself

17. Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay

18. High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathy

19. Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design

20. Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation

22. High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathy.

24. Interleukin 1/Toll-like Receptor-induced Autophosphorylation Activates Interleukin 1 Receptor-associated Kinase 4 and Controls Cytokine Induction in a Cell Type-specific Manner

25. The Master Regulator of the Cellular Stress Response (HSF1) Is Critical for Orthopoxvirus Infection

35. A tumor host range selection procedures identifies p150[sup sal2] as a target of polyoma virus...

36. Nonsense-mediated decay does not occur within the yeast nucleus.

37. 41-Week Study of Progressive Diabetic Nephropathy in the ZSF1 fa/faCP Rat Model.

38. Stricturing Crohn's disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions.

39. 41-Week Study of Progressive Diabetic Nephropathy in the ZSF1 fa/fa CP Rat Model.

Catalog

Books, media, physical & digital resources